Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

COVID-19 vaccination may trigger lupus in some people.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.